HealthEquity, Inc. (NASDAQ:HQY - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $107.62 and last traded at $106.79, with a volume of 623929 shares. The stock had previously closed at $104.63.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on HQY. Barrington Research restated an "outperform" rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. KeyCorp reaffirmed an "overweight" rating on shares of HealthEquity in a report on Tuesday, May 26th. Wall Street Zen cut shares of HealthEquity from a "buy" rating to a "hold" rating in a research report on Saturday. Citizens Jmp increased their price target on HealthEquity from $110.00 to $111.00 and gave the company a "market outperform" rating in a research note on Monday, June 1st. Finally, Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $110.93.
View Our Latest Report on HealthEquity
HealthEquity Stock Up 2.1%
The firm's 50-day simple moving average is $93.69 and its 200 day simple moving average is $85.95. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The stock has a market capitalization of $8.93 billion, a P/E ratio of 40.00, a PEG ratio of 1.76 and a beta of 0.21.
HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million during the quarter, compared to analysts' expectations of $352.02 million. The company's revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current year.
Insider Transactions at HealthEquity
In other news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares of the company's stock, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the business's stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the transaction, the executive vice president owned 52,244 shares in the company, valued at $4,963,180. This represents a 4.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 in the last 90 days. Corporate insiders own 1.60% of the company's stock.
Institutional Investors Weigh In On HealthEquity
Several hedge funds have recently bought and sold shares of HQY. Fifth Third Wealth Advisors LLC increased its stake in HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company's stock valued at $240,000 after buying an additional 116 shares during the period. Truist Financial Corp increased its stake in shares of HealthEquity by 4.9% during the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company's stock worth $232,000 after acquiring an additional 119 shares during the period. Fiduciary Trust Co raised its holdings in HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company's stock worth $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC raised its holdings in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company's stock worth $60,000 after purchasing an additional 123 shares in the last quarter. Finally, Merit Financial Group LLC lifted its position in HealthEquity by 8.9% in the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company's stock valued at $200,000 after purchasing an additional 172 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
About HealthEquity
(
Get Free Report)
HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.